Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer

The aim of this work is to establish novel strategies for the highly sensitive screening of cancer biomarkers in biological samples.To achieve this goal, we developed droplet-based microfluidic dPCR technique. Using a limiting dilution, individual DNA molecules are encapsulated within monodisperse d...

Full description

Bibliographic Details
Main Author: Pekin, Deniz
Language:English
Published: Université de Strasbourg 2013
Subjects:
Online Access:http://tel.archives-ouvertes.fr/tel-00856594
http://tel.archives-ouvertes.fr/docs/00/85/65/94/PDF/PEKIN_Deniz_2013_ED222.pdf
id ndltd-CCSD-oai-tel.archives-ouvertes.fr-tel-00856594
record_format oai_dc
spelling ndltd-CCSD-oai-tel.archives-ouvertes.fr-tel-008565942014-10-14T03:30:50Z http://tel.archives-ouvertes.fr/tel-00856594 2013STRAF007 http://tel.archives-ouvertes.fr/docs/00/85/65/94/PDF/PEKIN_Deniz_2013_ED222.pdf Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer Pekin, Deniz [SDV:AEN] Life Sciences/Food and Nutrition [SDV:AEN] Sciences du Vivant/Alimentation et Nutrition [SDV:SA] Life Sciences/Agricultural sciences [SDV:SA] Sciences du Vivant/Sciences agricoles Droplet microfluidics Cancer biomarkers Digital PCR The aim of this work is to establish novel strategies for the highly sensitive screening of cancer biomarkers in biological samples.To achieve this goal, we developed droplet-based microfluidic dPCR technique. Using a limiting dilution, individual DNA molecules are encapsulated within monodisperse droplets of a water-in-oil emulsion created with a microfluidic device. Fluorescent TaqMan® probes targeting the screened cancer biomarkers allow the detection of mutations. We focused on the mutations in the human KRAS gene for the development of our test. This method is also transposable in a multiplexed format for the parallel detection of multiple mutations in clinical samples.The developed technique allowed the precise quantification of a mutated KRAS gene in the presence of a 200,000-fold excess of un-mutated KRAS genes and enabled the determination of mutant allelic specific imbalance (MASI) in several cancer cell-lines. We validated our technique by screening for KRAS mutations in the blood plasma and tumor samples from patients with metastatic colorectal cancer. 2013-02-26 eng PhD thesis Université de Strasbourg
collection NDLTD
language English
sources NDLTD
topic [SDV:AEN] Life Sciences/Food and Nutrition
[SDV:AEN] Sciences du Vivant/Alimentation et Nutrition
[SDV:SA] Life Sciences/Agricultural sciences
[SDV:SA] Sciences du Vivant/Sciences agricoles
Droplet microfluidics
Cancer biomarkers
Digital PCR
spellingShingle [SDV:AEN] Life Sciences/Food and Nutrition
[SDV:AEN] Sciences du Vivant/Alimentation et Nutrition
[SDV:SA] Life Sciences/Agricultural sciences
[SDV:SA] Sciences du Vivant/Sciences agricoles
Droplet microfluidics
Cancer biomarkers
Digital PCR
Pekin, Deniz
Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer
description The aim of this work is to establish novel strategies for the highly sensitive screening of cancer biomarkers in biological samples.To achieve this goal, we developed droplet-based microfluidic dPCR technique. Using a limiting dilution, individual DNA molecules are encapsulated within monodisperse droplets of a water-in-oil emulsion created with a microfluidic device. Fluorescent TaqMan® probes targeting the screened cancer biomarkers allow the detection of mutations. We focused on the mutations in the human KRAS gene for the development of our test. This method is also transposable in a multiplexed format for the parallel detection of multiple mutations in clinical samples.The developed technique allowed the precise quantification of a mutated KRAS gene in the presence of a 200,000-fold excess of un-mutated KRAS genes and enabled the determination of mutant allelic specific imbalance (MASI) in several cancer cell-lines. We validated our technique by screening for KRAS mutations in the blood plasma and tumor samples from patients with metastatic colorectal cancer.
author Pekin, Deniz
author_facet Pekin, Deniz
author_sort Pekin, Deniz
title Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer
title_short Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer
title_full Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer
title_fullStr Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer
title_full_unstemmed Development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer
title_sort development of novel droplet-based microfluidic strategies for the molecular diagnosis of cancer
publisher Université de Strasbourg
publishDate 2013
url http://tel.archives-ouvertes.fr/tel-00856594
http://tel.archives-ouvertes.fr/docs/00/85/65/94/PDF/PEKIN_Deniz_2013_ED222.pdf
work_keys_str_mv AT pekindeniz developmentofnoveldropletbasedmicrofluidicstrategiesforthemoleculardiagnosisofcancer
_version_ 1716717033489432576